Abstract
More and more frequently, hospitals are expanding their services to incorporate complementary therapies into their medical settings. One of the first successful models for a hospital-based integrative therapies center was developed in Boston, Massachusetts at Dana-Farber Cancer Institute, a Harvard University academic medical center and world-renowned cancer patient care and research institute. Driven by patient advocacy and a desire to provide the most safe and efficacious care possible, the Leonard P. Zakim Center for Integrative Therapies at Dana-Farber unites leading cancer experts with complementary therapy practitioners in order to offer patients a more holistic, comprehensive cancer care. The Zakim Center is an interdisciplinary program that uses a three-prong approach by offering complementary therapies including acupuncture, massage, nutrition, and others to enhance patients’ quality of life and to help them with symptom management, while at the same time, educating staff and patients about these therapies and researching them in order to advance their scientific evidence base. Development of this Center and the concept of a new discipline, “integrative oncology,’ required much communication, strategic planning, leadership commitment, and the diligence of many individuals. Through focused program and operational development, active institutional collaborations, and the concerted efforts of the whole Dana-Farber community, a premier comprehensive integrative therapies center that is affordable and accessible was established and continues to flourish and grow extensively today to meet the needs of patients, clinicians, and researchers at Dana-Farber Cancer Institute.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Complementary Therapies: Empowering the Cancer Patient, Dana-Farber Cancer Institute, ISBN No. 1-890921-B, Xenejenex Health Care Communication.
Cassileth B, Deng G. Complementary and alternative therapies for cancer. Oncologist 2004, 9, 80–89.
Richardson M, Sanders T, Palmer J, et al. Complementary/alternative medicine use in a comprehensive cancer center and the implications on oncology. J Clin Oncol 2000, 18, 2505–2514.
DiGianni L, Garber J. Winer, E. Complementary and alternative medicine use among women with breast cancer. J Clin Oncol 2002, 20, 34s–38s.
Boon H, Westlakek S, Gray R, Fleshner N, Gavin A, Brown J, Goel V. Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics. Urology 2003, 62, 849–853.
Eisenberg D. Perceptions about complementary therapies relative to conventional therapies among adults who use both: results from a national survey. Ann Intern Med 2001, 135, 344–351.
Richardson MA, Mâsse LC, Nanny K, Sanders C. Discrepant views of oncologists and cancer patients on complementary/alternative medicine. Support Cancer Care 2004, 12, 797–804.
Doherty-Gilman A, Richardson P, Neuberg D, Momtaz P, Bears J, Odaka B, Rones R, Kerr C, Nazir F, Ott MJ, Rosenthal DS, Freedman A. A Pilot Study of Immunologic Activity, Quality of Life, and Physical Status in Connection with Two Exercise Programs (Modified Exercise and Qigong) in Patients with Breast Cancer, Prostate Cancer, or Chronic Lymphocytic Leukemia (CLL). Plenary Synopsis from Society for Integrative Oncology (SIO) meeting, Journal of Society of Integrative Oncology, December 2005, 3 (4), 133–135.
Dean-Clower E, Doherty-Gilman A, Baker F, Kaw C, Donoria W, Manola J, DellaCroce A, Sugumar A, Ohiri K, Geng A, Rosenthal DS. Effect of Acupuncture on the Pain, Nausea, and Quality of Life of Patient with Advanced Cancer. Plenary Synopsis from Society for Integrative Oncology (SIO) meeting, Journal of Society of Integrative Oncology, December 2005, 3 (4), 130–131.
Lu W, Hu D, Dean-Clower E, Matulonis U, Rosenthal DS. A Systematic Review on Acupuncture Trials for Chemotherapy-Induced Leukopenia, Plenary Synopsis from SIO meeting. Plenary Synopsis from Society for Integrative Oncology (SIO) meeting, Journal of Society of Integrative Oncology, December 2005, 3 (4), 135–137.
Oh WK, Kantoff PW, Weinberg V, Jones G, Rini BI, Derynck MK, Bok R, Smith MR, Bubley GJ, Rosen RT, DiPaola RS, Small EJ. Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer. J Clin Oncol 2004, Sep 15, 22 (18), 3705–3712.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press
About this chapter
Cite this chapter
Rosenthal, D.S., Doherty-Gilman, A., Medeiros, C., DeCristofaro, S., Dean-Clower, E. (2008). Integrative Oncology—Leonard P. Zakim Center. In: Cohen, L., Markman, M. (eds) Integrative Oncology. Current Clinical Oncology. Humana Press. https://doi.org/10.1007/978-1-59745-183-3_7
Download citation
DOI: https://doi.org/10.1007/978-1-59745-183-3_7
Publisher Name: Humana Press
Print ISBN: 978-1-58829-869-0
Online ISBN: 978-1-59745-183-3
eBook Packages: MedicineMedicine (R0)